Fig. 1From: Early risk assessment of circulating endothelial progenitor cells and plasma stromal cell-derived factor-1 for nondisabling ischemic cerebrovascular eventsFlow cytometry results revealed double-positive CD34/KDR cells in each group: in the HR-NICE group (Fig. 1a) and the NHR-NICE group (Fig. 1b)Back to article page